Benzinga | Oct 21, 2021 12:11PM EDT

RBC Capital Maintains Sector Perform on Biogen, Lowers Price Target to $295

RBC Capital analyst Brian Abrahams maintains Biogen (NASDAQ:BIIB) with a Sector Perform and lowers the price target from $325 to $295.